Aurinia Pharmaceuticals's total assets for Q1 2026 were $724.00M, a decrease of -3.67% from the previous quarter. AUPH total liabilities were $156.37M for the fiscal quarter, a -8.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.